NCT05065762View on ClinicalTrials.gov

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

CompletedOBSERVATIONAL
Enrollment

232

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
Psoriasis
Trial Locations (1)

27560

Local Institution, Morrisville

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05065762 - Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment | Biotech Hunter | Biotech Hunter